Related Experiment Video
Updated: Apr 16, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Overview of Gastric Cancer Prevention Initiatives in Europe
Marcis Leja1, Danute Ražuka-Ebela1, Bojan Tepes2
1Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
European gastric cancer prevention strategies are being developed and evaluated through various studies. Ongoing research focuses on Helicobacter pylori (H. pylori) screening and treatment, assessing feasibility, cost-effectiveness, and population acceptability to reduce mortality.
Area of Science:
- Oncology
- Public Health
- Gastroenterology
Background:
- Gastric cancer remains a significant health concern in Europe, prompting calls for effective prevention strategies.
- Reducing gastric cancer mortality is a key public health objective in the European region.
Purpose of the Study:
- To review and summarize current gastric cancer prevention initiatives across Europe.
- To highlight ongoing research and development in H. pylori screening and treatment strategies.
Main Methods:
- Review of current European gastric cancer prevention initiatives.
- Analysis of studies including GISTAR (H. pylori screen-and-treat, pepsinogen testing), EUROHELICAN/TOGAS (H. pylori strategies in young adults, cost-effectiveness, precancerous conditions), EUGastScreen (simultaneous H. pylori and colorectal cancer screening), and Hp-EuReg (clinical data collection).
- Inclusion of European guidelines development and updated European Code Against Cancer recommendations on H. pylori management.
Main Results:
- Multiple initiatives are evaluating H. pylori screen-and-treat strategies in diverse populations and settings.
- Research is assessing feasibility, acceptability, cost-effectiveness, and long-term outcomes of H. pylori eradication.
- New guidelines and recommendations for H. pylori management are being integrated into cancer prevention frameworks.
Conclusions:
- Ongoing European initiatives are generating crucial evidence for implementing gastric cancer prevention strategies.
- Data on feasibility, population and stakeholder acceptability, and cost-effectiveness are vital for future policy.
- Further implementation studies are necessary to fully establish effective gastric cancer prevention programs.
Related Concept Videos
Cancer Prevention
Cancer Prevention
Some...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

